STOCK OPTION AGREEMENT (Director)Stock Option Agreement • August 29th, 2018 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT made and entered into as of ______, 20___, by and between OncoCyte Corporation, a California corporation (the “Company”), and _________, a director (the “Optionee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),
INCENTIVE*][NON-QUALIFIED**] STOCK OPTION AGREEMENTNon-Qualified • August 29th, 2018 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT made and entered into as of _______, 20XX, by and between OncoCyte Corporation, a California corporation (the “Company”), and __________, an employee (the “Employee”) of the Company or of a subsidiary of the Company (hereinafter included within the term “Company”) within the meaning of Section 425(f) of the Internal Revenue Code of 1986, as amended (the “Code”),
ONCOCYTE CORPORATION Restricted Stock Units Award AgreementRestricted Stock Units Award Agreement • August 29th, 2018 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
This Restricted Stock Units Award Agreement (the “Award Agreement”) memorializes the grant on ___________ (the “Grant Date”) by ONCOCYTE CORPORATION (the “Company”) to ____________ (“Participant”) of the number of Restricted Stock Units (the “Units”) indicated below under the Company’s 2018 Equity Incentive Plan (the “Plan”), including rights to Dividend Equivalents thereon. Each Unit granted hereunder represents a right to receive one common share, no par value, of the Company (“Common Stock”).
